TITLE

Osteogenesis imperfecta in dachshunds

AUTHOR(S)
Schütz, Ekkehard; Brenig, Bertram; Scharfenstein, Melanie; Drögemüller, Cord; Leeb, Tosso
PUB. DATE
March 2013
SOURCE
Veterinary Record: Journal of the British Veterinary Association;3/23/2013, Vol. 172 Issue 12, p319
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Population screening for the mutation associated with osteogenesis imperfecta in dachshunds" by J. Eckardt and colleagues in the 2013 issue.
ACCESSION #
86439610

 

Related Articles

  • Letters. Eckardt, Judith; Kluth, Susanne; Dierks, Claudia; Philipp, Ute; Distl, Ottmar // Veterinary Record: Journal of the British Veterinary Association;3/23/2013, Vol. 172 Issue 12, p319 

    A response from the author of the article "Population screening for the mutation associated with osteogenesis imperfecta in dachshunds" in the 2013 issue is presented.

  • A Missense Mutation in the SERPINH1 Gene in Dachshunds with Osteogenesis Imperfecta. Drögemüller, Cord; Becker, Doreen; Brunner, Adrian; Haase, Bianca; Kircher, Patrick; Seeliger, Frank; Fehr, Michael; Baumann, Ulrich; Lindblad-Toh, Kerstin; Leeb, Tosso // PLoS Genetics;Jul2009, Vol. 5 Issue 7, p1 

    Osteogenesis imperfecta (OI) is a hereditary disease occurring in humans and dogs. It is characterized by extremely fragile bones and teeth. Most human and some canine OI cases are caused by mutations in the COL1A1 and COL1A2 genes encoding the subunits of collagen I. Recently, mutations in the...

  • Population screening for the mutation associated with osteogenesis imperfecta in dachshunds. Eckardt, J.; Kluth, S.; Dierks, C.; Philipp, U.; Distl, O. // Veterinary Record: Journal of the British Veterinary Association;4/6/2013, Vol. 172 Issue 14, following p364 

    Osteogenesis imperfecta (OI) is a genetic disorder causing defects in the development of collagen type I. Clinical signs of affected dachshunds include multiple fractures of bones, joint hyperlaxity and dentinogenesis imperfecta. Recently, a recessive mutation in the SERPINH1 gene was detected...

  • Life expectancy in osteogenesis imperfecta. Paterson, Colin R.; Ogston, Simon A. // BMJ: British Medical Journal (International Edition);2/10/96, Vol. 312 Issue 7027, p351 

    Examines the life expectancy of patients with osteogenesis imperfecta in Great Britain. Description of the disease.

  • Gnathodiaphyseal dysplasia. Herman, T E; Siegel, M J; Sargar, K // Journal of Perinatology;May2014, Vol. 34 Issue 5, p412 

    The article presents a case study of an infant who was born at term to a 33-year old gravida 2, para 1 mother by cesarean section due to the sonographic finding of fractures and bowing of long bones in utero, which raised the possibility of osteogenesis imperfecta. It notes the details of the...

  • Osteogenesis Imperfecta (OI).  // Palaestra;Spring96, Vol. 12 Issue 2, p55 

    Presents information on Osteogenesis Imperfecta (OI), a genetic disorder which is characterized by bones that break easily for no apparent reason. Approximate number of persons affected with OI in the United States; Contact information.

  • Corrigendum: Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Cabral, Wayne A; Chang, Weizhong; Barnes, Aileen M; Weis, MaryAnn; Scott, Melissa A; Leikin, Sergey; Makareeva, Elena; Kuznetsova, Natalia V; Rosenbaum, Kenneth N; Tifft, Cynthia J; Bulas, Dorothy I; Kozma, Chahira; Smith, Peter A; Eyre, David R; Marini, Joan C // Nature Genetics;Jul2008, Vol. 40 Issue 7, p927 

    A correction to the article "Prolyl 3-Hydroxylase One Deficiency Causes a Recessive Metabolic Bone Disorder Resembling Lethal/Severe Osteogenesis Imperfecta," by Wayne A. Cabral, Weizhong Chang and Aileen M. Barnes is presented.

  • Beneficial Effect of Bisphosphonate During Five Years of Treatment of Severe Osteogenesis Imperfecta. Lampe, John B.; Langdon, David R. // Clinical Pediatrics;Apr1999, Vol. 38 Issue 4, p251 

    Presents an abstract of the article `Beneficial Effect of Bisphosphonate During Five Years of Treatment of Severe Osteogenesis Imperfecta,' by E. Astrom and S. Soderhall.

  • Fragile bones don't break teen's spirit.  // Current Science;11/19/93, Vol. 79 Issue 7, p12 

    Profiles Brianne Schwantes, a teenager afflicted with osteogenesis imperfecta (OI), a disease that causes brittle bones. Condition since infancy; Factors causing the disease; Brianne's ability to cope; Speech before House and Senate subcommittees.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics